Bioscience-Lost in Translation?

Precision Medicine holds the key to health system transformation. Professor Richard Barker's latest book - Bioscience-Lost in Translation? - highlights the global problem of the ineffective translation of bioscience innovation into health system improvements and its consequences, analyses the underlying causative factors and provides powerful prescriptions for change to close the gap. It contrasts the progress in biomedicine with other areas of scientific and technological endeavour, such as information technology, in which there are faster and more reliable returns for society.

New-Medicine-Partners-Lost-in-Translation-Book-Richard-Barker.jpg
This is a timely and provocative analysis. It is crucially important that researchers, clinicians, industry, and regulators adapt effectively to the new era of stratified medicine. This book is a welcome contribution to the debate.”
— Professor Jeremy Farrar, Executive Director, The Wellcome Trust, UK
Richard Barker presents a provocative and thoughtful review of the healthcare ecosystem, demonstrating time and again that communication and collaboration across the stakeholder community are essential to realizing patient benefits from biomedical innovation.”
— Dr Barbara Lopez Kunz, Global Chief Executive, Drug Information Association, Switzerland
Richard Barker, drawing on a quarter of a century of deep practical involvement in the topic, has written an invaluable synthesis of the factors that account for the disappointing rate of translation of science into affordable treatments to address unmet clinical need. Crucial will be forging of transparent productive relationships between academia, industry and an enlightened regulatory system. Essential reading for all those interested in making the medical innovation process faster, more productive and sustainable.”
— Professor Sir John Tooke, co-Chair of the Centre for the Advancement of Sustainable Medical Innovation, UK, former Vice-Provost of University College London, and former President of the UK Academy of Medical Sciences
Concisely frames the rich, dynamic environment for biologic/medical science with all the opportunities and challenges and offers orderly, thoughtful, practical approaches and solutions to facilitate and optimize medical innovation science. This book is suitable for both the knowledgeable scientific and the interested lay communities.”
— Dr Michael Friedman, Emeritus Chief Executive, City of Hope Cancer Center, Duarte, CA, USA and board member of life science companies
This book provides an overview and in-depth analysis of medical science, drug development, etc., along with recommendations that are impressive. Amazing to say the least.”
— Mike Casey, board member and former Chief Executive of US biotech companies and former senior executive at Johnson & Johnson
This is an important and timely book. Richard Barker comprehensively reviews current progress, but perhaps more importantly points out encouraging paths of translation as we move forward. In doing so, he provides a comprehensive scientific and socio-cultural rationale and basis for closing the “collaboration gap”, for bridging scientific advances, new product development and evaluation, and clinical care.”
— Stephen P. Spielberg, MD, PhD, former Dean, Dartmouth Medical School, Hannover, NH, USA, former Deputy Commissioner, US FDA, USA, and Editor-in-Chief, Therapeutic Innovation and Regulatory Science

Read more about the book here